Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2024-02-29 Major Shareholding Noti…
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Change in substantial holding from PPT 10 pages 616.9KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, Section 671B, which pertains to notices of change of interests of substantial holders. It details changes in voting power and relevant interests of a substantial shareholder, Perpetual Limited, in Healius Limited. The content includes dates of changes, previous and present voting power percentages, and transaction details in annexures. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is substantive and not merely an announcement or certification, and it does not fit other categories such as director dealings or capital changes. Therefore, the correct classification is MRQ with high confidence.
2024-02-29 English
Half Yearly Report and Accounts 30 pages 460.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Healius Limited Appendix 4D – Half-Year Report' and includes detailed financial data for the half-year ended 31 December 2023. It contains comprehensive financial statements, directors' report, auditor's review report, and notes to the consolidated financial statements. The presence of interim financial data, including profit and loss, balance sheet, cash flow, and detailed operational review, confirms this is a substantive financial report for a period shorter than a full fiscal year. The document is not merely an announcement or a certification but a full interim report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-02-26 English
Healius announces 1H 2024 results 3 pages 246.4KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 27 February 2024, presenting detailed financial results for the half year ended 31 December 2023 (1H24). It includes comprehensive financial data such as revenue, EBIT, EBITDA, impairment charges, net debt, and gearing ratios. The text discusses business segment performance, transformation programs, balance sheet details, and outlook for the full fiscal year 2024. It also mentions a webcast for analysts and investors to discuss the results. The presence of detailed financial statements and analysis for a half-year period indicates this is an Interim / Quarterly Report rather than a brief earnings release or a simple announcement. The document length (8403 characters) and content confirm it is a substantive financial report, not merely an announcement of a report. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2024
2024-02-26 English
Half Year 2024 Results Presentation 29 pages 1.9MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation including forward-looking statements, financial performance data, operational updates, and strategic initiatives. It contains extensive financial figures such as revenue, EBIT, NPAT, and segment-specific performance metrics. The presence of slides with CEO and CFO commentary, operational and financial highlights, and strategic plans indicates this is a presentation aimed at investors or analysts. The document references an Appendix 4D released to the ASX, which is typical for interim financial disclosures in Australia. The content is consistent with an investor presentation rather than a full annual or interim report, earnings release, or regulatory filing. Therefore, the document best fits the category of an Investor Presentation (IP).
2024-02-26 English
Healius announces Trading Update for FY 2024 2 pages 151.8KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement titled 'Healius announces Trading Update for FY 2024'. It provides updated guidance on EBITDA and EBIT for the first half and full fiscal year 2024, discusses volume growth, market conditions, and a planned restructuring program. It also mentions a significant non-cash impairment charge to goodwill. The document is a trading update with financial guidance and operational commentary but does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more detailed than a simple earnings release (ER) but primarily serves as an update on trading and outlook. Given the content and length (4756 characters), this fits best as a Capital/Financing Update (CAP) because it updates on financial expectations and business restructuring plans affecting future capital and operations. Therefore, the classification is CAP with high confidence.
2024-02-20 English
Webcast Details for Healius 1H 2024 Results 1 page
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 February 2024, providing details about a webcast for the upcoming release of Healius Limited's HY 2024 results scheduled for 27 February 2024. It includes information on how to register for the webcast and teleconference to discuss the results. The document does not contain any financial data or the actual results but is an announcement about the upcoming earnings release and related investor briefing. According to the 'MENU VS MEAL' rule, this is not the earnings release itself but a notice about it. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2024-02-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.